ID Source | ID |
---|---|
PubMed CID | 9038 |
SCHEMBL ID | 259934 |
MeSH ID | M0081647 |
Synonym |
---|
ai3-51712 |
o,o,o-trimethyl phosphorothioate |
o,o,o-trimethylthiofosfat [czech] |
hc 7900 |
trimethylthiophosphate |
o,o,o-trimethylester kyseliny thiofosforecne [czech] |
sd 4741 |
trimethylthiofosfat [czech] |
o,o,o-trimethyl phosphorothioic acid ester |
ccris 5569 |
o,o,o-trimethyl thiophosphate |
phosphorothioic acid, o,o,o-trimethyl ester |
152-18-1 |
o,o,o-trimethylester kyseliny thiofosforecne |
trimethylthiofosfat |
o,o,o-trimethylthiofosfat |
trimethyl thiophosphate |
SCHEMBL259934 |
methyl phosphorothioate ((meo)3ps) |
(ch3o)3ps |
trimethoxyphosphine sulfide |
7900-hc |
o,o',o''-trimethyl thiophosphate |
trimethyl thionophosphate |
DTXSID30164927 |
mfcd00014888 |
o,o,o-trimethylphosphorthioate; trimethoxy(thioxo)-lambda5-phosphane |
o,o,o-trimethylthiophosphate |
o,o,o-trimethylphosphorothioate |
FT-0739995 |
trimethoxy(sulfanylidene)-lambda5-phosphane |
o,o,o-trimethylthiophosphate 100 microg/ml in acetonitrile |
Q63396031 |
EN300-107685 |
E80832 |
CS-0001866 |
69JRL96TGY |
hc-7900 |
sk-4741 |
Excerpt | Relevance | Reference |
---|---|---|
" Animals (five per group) were dosed with OOS-TMP at 40 mg/kg and sacrificed on the 1st, 3rd or 7th day after treatment." | ( Enhanced levels of lipid peroxidation and xanthine oxidase activity in the lung of male Sprague-Dawley rats following treatment with O,O,S-trimethyl phosphorothioate. Koizumi, A; Ohtaka, K, ) | 0.13 |
"The O-dealkylation of pentoxyresorufin, a substrate for P450 2B1, was decreased in lung microsomes from rats dosed with O,O,S-trimethylphosphorodithioate, O,O,O-trimethylphosphorothioate, bromophos, fenitrothion, p-xylene and 2,4-dichloro-(6-phenylphonoxy)ethylamine." | ( Inhibition and induction of cytochrome P450 isoenzymes in rat lung. Dinsdale, D; Verschoyle, RD; Wolf, CR, 1993) | 0.29 |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 4 (50.00) | 18.7374 |
1990's | 4 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (11.81) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 13 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |